289 related articles for article (PubMed ID: 37451822)
1. Targeting Solid Cancers with a Cancer-Specific Monoclonal Antibody to Surface Expressed Aberrantly O-glycosylated Proteins.
Aasted MKM; Groen AC; Keane JT; Dabelsteen S; Tan E; Schnabel J; Liu F; Lewis HS; Theodoropulos C; Posey AD; Wandall HH
Mol Cancer Ther; 2023 Oct; 22(10):1204-1214. PubMed ID: 37451822
[TBL] [Abstract][Full Text] [Related]
2. A strategy for generating cancer-specific monoclonal antibodies to aberrant O-glycoproteins: identification of a novel dysadherin-Tn antibody.
Steentoft C; Fuhrmann M; Battisti F; Van Coillie J; Madsen TD; Campos D; Halim A; Vakhrushev SY; Joshi HJ; Schreiber H; Mandel U; Narimatsu Y
Glycobiology; 2019 Apr; 29(4):307-319. PubMed ID: 30726901
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of antibody binding to mucin glycopeptides in lung cancer.
Qu J; Yu H; Li F; Zhang C; Trad A; Brooks C; Zhang B; Gong T; Guo Z; Li Y; Ragupathi G; Lou Y; Hwu P; Huang W; Zhou D
Int J Oncol; 2016 Feb; 48(2):587-94. PubMed ID: 26692014
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an immunodominant cancer-specific O-glycopeptide epitope in murine podoplanin (OTS8).
Steentoft C; Schjoldager KT; Cló E; Mandel U; Levery SB; Pedersen JW; Jensen K; Blixt O; Clausen H
Glycoconj J; 2010 Aug; 27(6):571-82. PubMed ID: 20721622
[TBL] [Abstract][Full Text] [Related]
5. Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides.
Sharma P; Marada VVVR; Cai Q; Kizerwetter M; He Y; Wolf SP; Schreiber K; Clausen H; Schreiber H; Kranz DM
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15148-15159. PubMed ID: 32541028
[TBL] [Abstract][Full Text] [Related]
6. Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity.
Lavrsen K; Madsen CB; Rasch MG; Woetmann A; Ødum N; Mandel U; Clausen H; Pedersen AE; Wandall HH
Glycoconj J; 2013 Apr; 30(3):227-36. PubMed ID: 22878593
[TBL] [Abstract][Full Text] [Related]
7. Effective Targeting of TAG72
Murad JP; Kozlowska AK; Lee HJ; Ramamurthy M; Chang WC; Yazaki P; Colcher D; Shively J; Cristea M; Forman SJ; Priceman SJ
Front Immunol; 2018; 9():2268. PubMed ID: 30510550
[TBL] [Abstract][Full Text] [Related]
8. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
[TBL] [Abstract][Full Text] [Related]
9. Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy.
Zhou D; Xu L; Huang W; Tonn T
Molecules; 2018 May; 23(6):. PubMed ID: 29857542
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
[TBL] [Abstract][Full Text] [Related]
11. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes.
Wandall HH; Blixt O; Tarp MA; Pedersen JW; Bennett EP; Mandel U; Ragupathi G; Livingston PO; Hollingsworth MA; Taylor-Papadimitriou J; Burchell J; Clausen H
Cancer Res; 2010 Feb; 70(4):1306-13. PubMed ID: 20124478
[TBL] [Abstract][Full Text] [Related]
12. Synthetic glycopeptides from the mucin family as potential tools in cancer immunotherapy.
Becker T; Dziadek S; Wittrock S; Kunz H
Curr Cancer Drug Targets; 2006 Sep; 6(6):491-517. PubMed ID: 17017874
[TBL] [Abstract][Full Text] [Related]
13. Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.
Posey AD; Schwab RD; Boesteanu AC; Steentoft C; Mandel U; Engels B; Stone JD; Madsen TD; Schreiber K; Haines KM; Cogdill AP; Chen TJ; Song D; Scholler J; Kranz DM; Feldman MD; Young R; Keith B; Schreiber H; Clausen H; Johnson LA; June CH
Immunity; 2016 Jun; 44(6):1444-54. PubMed ID: 27332733
[TBL] [Abstract][Full Text] [Related]
14. CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice.
Porcellini S; Asperti C; Corna S; Cicoria E; Valtolina V; Stornaiuolo A; Valentinis B; Bordignon C; Traversari C
Front Immunol; 2020; 11():99. PubMed ID: 32117253
[TBL] [Abstract][Full Text] [Related]
15. A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide.
Trabbic KR; Whalen K; Abarca-Heideman K; Xia L; Temme JS; Edmondson EF; Gildersleeve JC; Barchi JJ
Sci Rep; 2019 Apr; 9(1):5662. PubMed ID: 30952968
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
Hanisch FG; Stadie T; Bosslet K
Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
[TBL] [Abstract][Full Text] [Related]
17. Immunology of O-glycosylated proteins: approaches to the design of a MUC1 glycopeptide-based tumor vaccine.
Hanisch FG; Ninkovic T
Curr Protein Pept Sci; 2006 Aug; 7(4):307-15. PubMed ID: 16918445
[TBL] [Abstract][Full Text] [Related]
18. [Recent advances in glycopeptide enrichment and mass spectrometry data interpretation approaches for glycoproteomics analyses].
Liu L; Qin H; Ye M
Se Pu; 2021 Oct; 39(10):1045-1054. PubMed ID: 34505426
[TBL] [Abstract][Full Text] [Related]
19. CAR T cells redirected against tumor-specific antigen glycoforms: can low-sugar antigens guarantee a sweet success?
Safarzadeh Kozani P; Safarzadeh Kozani P; Rahbarizadeh F
Front Med; 2022 Jun; 16(3):322-338. PubMed ID: 35687277
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal Antibody Targeting Sialyl-di-Lewis
Tivadar ST; McIntosh RS; Chua JX; Moss R; Parsons T; Zaitoun AM; Madhusudan S; Durrant LG; Vankemmelbeke M
Mol Cancer Ther; 2020 Mar; 19(3):790-801. PubMed ID: 31871270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]